WallStSmart

Navitas Semiconductor Corp (NVTS)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 464% more annual revenue ($258.90M vs $45.92M). ZEPP leads profitability with a -15.5% profit margin vs -254.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

NVTS

Avoid

17

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 4.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NVTSOvervalued (-11.7%)

Margin of Safety

-11.7%

Fair Value

$7.84

Current Price

$15.48

$7.64 premium

UndervaluedFair: $7.84Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVTS0 strengths · Avg: 0/10

No standout strengths identified

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

NVTS4 concerns · Avg: 3.0/10
Price/BookValuation
8.0x4/10

Trading at 8.0x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-29.5%2/10

ROE of -29.5% — below average capital efficiency

Revenue GrowthGrowth
-59.4%2/10

Revenue declined 59.4%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : NVTS

NVTS has a balanced fundamental profile.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : NVTS

The primary concerns for NVTS are Price/Book, EPS Growth, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NVTS profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

NVTS carries more volatility with a beta of 3.14 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 17/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Navitas Semiconductor Corp

TECHNOLOGY · SEMICONDUCTORS · USA

Navitas Semiconductor Corp (NVTS) is a pioneering leader in gallium nitride (GaN) power semiconductor technology, specializing in high-efficiency power converters across diverse markets, including consumer electronics, data centers, and electric vehicles. The company prioritizes sustainability by leveraging its proprietary technologies to deliver energy-efficient solutions that surpass environmental regulations. Supported by a strong intellectual property portfolio and strategic partnerships, Navitas is well-positioned to exploit the burgeoning demand for advanced power solutions, playing a vital role in the global electrification and energy transition while targeting substantial growth and enhanced shareholder value.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?